The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Merck & Company

  • MRK
  • NYSE
  • Consumer Products
  • Latest 56.74
  • Currency US$
  • Change -1.34
  • Percent Change -2.307 %
  • Volume 10,120,747
  • Thu Jul 31, 2014 04:01 PM EDT NYSE data delayed 15 minutes.
  • Open 57.76
  • Previous Close 58.08
  • High 58.07
  • Low 56.72
  • Bidx0 56.74
  • Askx0 57.61
  • 52-week High05/01 59.84
  • 52-week Low11/01 44.62
  • Beta 0.49
  • Market Cap 166,850.77M
  • EPS 3.52
  • P/E 16.119
  • Forward P/E 15.50
  • PEG 3.68
  • Annual Dividend 1.76
  • Yield 3.102

News

Financials & Calendars

Income Statement

  • Sales $43,625,000,000
  • Earnings $4,516,000,000
  • Return on Equity 8.61%

Cash Flow

  • Cash Flow --
  • Cash $15,828,000,000
  • Current Ratio 1.84

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $108,460,000,000
  • Liabilities $55,896,000,000
  • Liabilities-to-Equity Ratio 1.06

Price Ratios

  • Price to Sales 3.82
  • Price to Book 3.17
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Jul 29 $0.81 Oct 27 $0.88
Surprises Jul 29 4.94% n/a n/a
Dividends Jun 12 $0.44 n/a n/a
Splits n/a -- n/a n/a

12 months ended Aug 01, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.

Related Securities
Symbol Type Latest % Chg

Officers

  • KENNETH C. FRAZIER Chairman; President and Chief
  • PETER N. KELLOGG Executive Vice President and C
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

ONE MERCK DRIVE P.O. BOX 100
WHITEHOUSE STATION, NJ
08889-0

Phone: (908)-423-4840
Fax: (908)-7351253


www.merck.com

Ideas & Discussion

Live Discussion of MRK on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.